Michael S. Brown - Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
REGN on Nasdaq
All Insider Reports
All Insider Reports

Michael S. Brown - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by Michael S. Brown for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.16K $4.36M $708.19 Jan 2, 2025 by Trust
Common Stock 5K $3.54M $708.19 Jan 2, 2025 by SLAT
Common Stock 1.55K $1.1M $708.19 Jan 2, 2025 Direct
Non-Qualified Stock Option (right to buy) 1.96K Jan 2, 2025 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 Jun 14, 2024 Direct Common Stock

Transactions reported by Michael S. Brown for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.